Chloroquinesensitive

Chloroquinesensitive refers to strains of the malaria parasite, Plasmodium falciparum, that remain susceptible to the effects of the drug chloroquine. Chloroquine was once a cornerstone of malaria treatment and prevention due to its efficacy and low cost. However, widespread resistance to chloroquine has emerged in many parts of the world, making it ineffective against significant numbers of infections. Strains are classified as chloroquinesensitive if they can be eradicated by standard chloroquine treatment regimens. Conversely, chloroquine-resistant strains are those that can survive and multiply despite exposure to the drug. The development and spread of chloroquine resistance have necessitated the use of alternative antimalarial drugs in many regions. Monitoring the sensitivity of Plasmodium falciparum to chloroquine and other antimalarials is crucial for effective malaria control strategies and drug policy decisions. Laboratory tests, such as in vitro drug sensitivity assays, are used to determine the sensitivity status of parasite isolates. In clinical settings, treatment failure after chloroquine administration is an indicator of chloroquine resistance.